Inovio Pharmaceuticals Inc. closed $12.82 below its 52-week high ($14.75), which the company achieved on April 1st.

Inovalis REIT is an intriguing speculative opportunity. It's had a horrible past few years of performance and is now a penny ...

Inovio Pharmaceuticals Inc. closed $12.79 short of its 52-week high ($14.75), which the company achieved on April 1st.

State Street Corp raised its position in Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) by 11.7% in the third quarter, Holdings Channel.com reports. The institutional investor owned 490,662 ...

The company priced a public offering of 10 million shares of common stock and accompanying warrants. Discover Fast-Growing Stocks Every Month Inovio Pharmaceuticals Inc INO shares are trading ...

The delay in BLA submission for INO-3107 due to manufacturing issues with the CELLECTRA device could significantly impact Inovio's market position. This concern is reflected in the stock's recent ...

Inovio (INO) Pharmaceuticals announced that it intends to offer and sell shares of its common stock and accompanying warrants to purchase shares of its common stock, in an underwritten public ...

In terms of launching INO-3107, Shea and others chose their words ... the title comes from the prospect of potential gain if the stock recovers or snaps back. I do not expect Inovio to experience ...

Shares of Precigen PGEN have soared nearly 43% in the past week after the company provided an encouraging regulatory update ...